510(k) Report

510(k) · Cleared

Recalled · Class II · 2020

LiDCOunity v2 Hemodynamic Monitor

K163334510(k) TraditionalCleared Jun 5, 2017189-day reviewClass II21 CFR 870.1435Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lidco, Ltd. · DXG Computer, Diagnostic, Pre-Programmed, Single-Function

Cleared on Jun 5, 2017 after a 189-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 1 later device descends from it. It has been recalled once.

Decided
Jun 5, 2017
Review
189 days
Class
Class II
Product code
DXG
Recalls
1
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2026: 1 descendant cleared201620182020202220242026
  1. This deviceK163334 LiDCOunity v2 Hemodynamic MonitorLidco, Ltd. · 2017
  2. Descendant · cites it directly · 0 of its ownK253417 Masimo Root Monitoring SystemMasimo Corporation · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K253417Masimo Root Monitoring SystemMasimo Corporation · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K163334LiDCOunity v2 Hemodynamic MonitorLidco, Ltd.2017—
+1K253417Masimo Root Monitoring SystemMasimo Corporation2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K163334, 2017–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXG device

  1. #1 K253092 Argos Infinity (Rev. 1.0)score 11.1 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K253417Masimo Root Monitoring SystemMasimo Corporation20260

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Nov 19, 2020Class IIZ-0756-2021Labeling mix-upsThe expiration date on labeling is incorrect.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K253417 (Masimo Corporation, 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DXG devices

DXG Computer, Diagnostic, Pre-Programmed, Single-Function: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · DXG

1in 2025

2007: 12008: 52010: 42011: 32012: 22013: 32014: 62015: 12016: 12017: 12018: 22019: 22020: 12021: 12023: 12025: 12026 (partial year): 1
2007high 6 (2014) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXG

290in 2014

2008: 118 days median2010: 282 days median2011: 104 days median2013: 236 days median2014: 290 days median
2007high 290 (2014) · low 104 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXG

2in 2020

2007: 12008: 12009: 62010: 12020: 2
2007high 6 (2009) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXG

8in 2025

2007: 432008: 372009: 82010: 172011: 72012: 292013: 232014: 442015: 342016: 672017: 622018: 832019: 812020: 492021: 292022: 442023: 122024: 212025: 8
2007high 83 (2018) · low 7 (2011)2025

MAUDE reports naming product code DXG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—143
20085118137
20090—68
20104282117
2011310407
20122—029
20133236023
20146290044
20151—034
20161—067
20171—062
20182—083
20192—081
20201—249
20211—029
20220—044
20231—012
20240—021
20251—08
20261—0—

What is it indicated for?

The LiDCOunity Monitor is intended for use under the direct supervision of a licensed healthcare practitioner or by personnel trained in its proper use for: 1. The measurement of blood pressure, cardiac output and associated hemodynamic parameters in adult patients. 2. When connected to the BIS Module: monitoring the state of the brain by data acquisition of EEG signals and may be used as an aid in monitoring the effects of certain anesthetic agents. Use…

Read the full statement (265 words)

The LiDCOunity Monitor is intended for use under the direct supervision of a licensed healthcare practitioner or by personnel trained in its proper use for:

1. The measurement of blood pressure, cardiac output and associated hemodynamic parameters in adult patients.

2. When connected to the BIS Module: monitoring the state of the brain by data acquisition of EEG signals and may be used as an aid in monitoring the effects of certain anesthetic agents. Use of BIS monitoring to help guide anesthetic administration may be associated with the reduction of the incidence of awareness with recall in adults during general anesthesia and sedation.

3. When connected to the LiDCO CNAP Module it may be used for the continuous, non-invasive monitoring of arterial blood pressure in adults and pediatric (>4yrs) patients by medical professionals. The LiDCO CNAP Module is intended for use with the LiDCOunity Monitor

4. The measurement of cardiac output via Lithium Indicator Dilution in adult patients (>40Kg/881bs) with pre-inserted arterial and venous catheters, and for monitoring continuous blood pressure and cardiac output in patients with pre-existing peripheral arterial line access

5. In addition to arterial blood pressure parameters and cardiac output, the LiDCOunity Monitor calculates a number of derived parameters: Body Surface Area, Pulse Pressure Variation, Stroke Volume Variation, Cardiac Index, Stroke Volume, Stroke Volume Index, Systemic Vascular Resistance, Systemic Vascular Resistance Index, Oxygen Delivery/Index

Location of Use:

Suitable patients will be receiving treatment in the following areas:

Medical and Surgical Intensive Care Units

Operative Suites

Step Down / High Dependency Units

Trauma/Accident & Emergency Departments

Coronary Intensive Care Units

Cardiac Catheter Laboratories

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K163334: LiDCOunity v2 Hemodynamic Monitor.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K163334

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026